Drug Information

Drug General Information
Drug ID
D09IYM
Former ID
DIB002324
Drug Name
AT13148
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1 [523886]
Company
Astex pharmaceuticals
Structure
Download
2D MOL

3D MOL
Target and Pathway
Target(s) Rho associated protein kinase Target Info Modulator
References
Ref 523886ClinicalTrials.gov (NCT01585701) Phase I Study of AT13148, a Novel AGC Kinase Inhibitor. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.